EAST BUY(01797)
Search documents
新东方在线收获2025年度“雅思语培机构白金级合作伙伴”及“卓越在线之星”双项大奖
Huan Qiu Wang· 2026-02-13 08:32
新东方在线获雅思语培机构合作伙伴项目"2025年度卓越在线之星"奖项 来源:中国网 2026年2月12日,雅思考试主办方英国文化教育协会(British Council,BC)宣布"2025年度雅思官方合 作伙伴评级"结果。凭借在雅思教育领域的突出表现,新东方在线蝉联英国文化教育协会雅思语培机构 合作伙伴项目"白金级合作伙伴"称号,并斩获"2025年度卓越在线之星"奖项。 新东方在线获英国文化教育协会雅思语培机构"白金级合作伙伴"称号 在课程培训方面,从注重考试系统培训的直播班课及精讲系统课,到6至8人VIP小班,再到1对1定制化 课程,新东方在线根据学员的年龄结构、英语水平、目标分数、时间分配等不同需求,打造了多样化的 雅思产品,同时引入知心学习系统、AI口语陪练等功能辅助学习,真正实现了用科技赋能学习,打破 时空和场景限制。 在师资培训方面,新东方在线始终秉持严格的考核标准,全方位对授课教师的教学能力、课堂管理、服 务意识等方面进行标准化培训和管理。同时,新东方在线拥有多位雅思总分8分及以上和单项9分的老 师,凭借雄厚的师资力量为考生带来更加专业的备考指导。 据悉,新东方拥有中国大陆唯一官方正版授权剑桥雅 ...
东方甄选(01797) - 2026 - 中期财报
2026-02-13 08:30
East Buy Holding Limited ( 股份代碼 : 1797 ) ( 於開曼群島註冊成立的有限公司 ) 東方甄選控股有限公司 2026 中期報告 目錄 2 公司資料 4 財務摘要 5 業務概覽及展望 13 管理層討論及分析 20 其他資料 31 簡明綜合財務報表審閱報告 32 簡明綜合損益及其他全面收入表 33 簡明綜合財務狀況表 34 簡明綜合權益變動表 35 簡明綜合現金流量表 36 簡明綜合財務報表附註 59 釋義 公司資料 董事會 執行董事 俞敏洪先生, 主席兼首席執行官 尹強先生, 首席財務官 非執行董事 孫暢女士 獨立非執行董事 鄺偉信先生 林哲莹先生 閻焱先生 董事委員會 審核委員會 閻焱先生, 委員會主席 鄺偉信先生 林哲莹先生 薪酬委員會 林哲莹先生, 委員會主席 孫暢女士 閻焱先生 提名委員會 俞敏洪先生, 委員會主席 林哲莹先生 閻焱先生 聯席公司秘書 宋㛃女士 (於2025年8月22日獲委任) 馬詠儀女士 (於2025年8月22日獲委任) 張啟昌先生 (於2025年8月22日辭任) 授權代表 尹強先生 馬詠儀女士 (於2025年8月22日獲委任) 張啟昌先生 (於202 ...
线上线下年味浓 万家团圆备锦筵
Shang Hai Zheng Quan Bao· 2026-02-12 17:42
◎记者 张雪 王乔琪 腊月年味浓,人间烟火暖。随着马年春节临近,街头巷尾的年味日益浓郁。 从直播间里此起彼伏的讲解声,到超市货架上红彤彤的年饰与琳琅满目的商品;从产地直供的新鲜年 味,到"春节不打烊"的即时配送……线上线下零售企业铆足干劲、各展所长,以精心的筹备、暖心的服 务、创新的模式,让新春的幸福滋味触手可及。 线上抢"鲜":直播间里"云备年" 深夜十二点,东方甄选产品经理刘鑫的手机还在不停振动。社群里,消费者正陆续发来年货心愿:"有 没有适合老人的无糖糕点?""刺梨汁能不能出小包装?"——这些需求被一条条记下,几天后便会转化 为直播间里的上新链接。 "这款五红粉是大家在社区里反复推荐的年货好物,独立小包装,送长辈、自己吃都合适,今天直播间 专属福利。"东方甄选的直播间里,主播的讲解声清脆响亮。屏幕上,坚果炒货、海鲜礼盒、营养膳食 等年货轮番登场。作为线上年货采购的重要阵地,东方甄选的直播间里,一场场年味满满的"云备年"正 在火热上演。 春节是销售的黄金期,更是一场与时间的赛跑。"年前物流运力紧张,工厂的生产排期也满,我们必须 紧盯生产和物流环节。"刘鑫对上海证券报记者说,"我们制订了详细的备货计划,与供 ...
俞敏洪要开电商培训学校!他曾称“不是为了挣钱,而是为了让中国主播的整体水平提高”,东方甄选股价跌超9%
Mei Ri Jing Ji Xin Wen· 2026-02-10 11:29
每经编辑|程鹏 2月10日,新东方创始人、东方甄选董事长俞敏洪近日在直播间宣布,东方甄选计划于今年正式成立电商培训学校。 俞敏洪透露开办电商培训的初衷,当前各地相关部门对电商非常重视,常常说希望派人来培训一下。 图片来源:每经媒资库 他说,"其实我们也在摸索。但是我觉得,与其孤独地摸索,不如一起摸索。所以我们干脆在北京准备成立一个电商学校,让各个地方派这些电商的运营 人才、主播等,到北京去培训。因为北京人才聚集,可以请到好多人才来讲课。" 1月28日,东方甄选(01797.HK)发布了2026财年中期业绩公告,同比扭亏为盈。公司总营收达23.12亿元,同比增长5.7%,若剔除上财年同期部分收入 影响,实际增幅达17%;期内净溢利2.39亿元,较去年同期的净亏损9679.9万元实现扭亏为盈,增幅达347.7%。 公告显示,本期东方甄选自营产品及直播电商业务总GMV达41亿元。若剔除与辉同行直播间产生的GMV,总GMV比2025财年上半年的人民币36亿元增加 16.4%。渠道结构持续优化,抖音平台仍为核心流量来源,同时东方甄选App贡献的GMV占比提升至18.5%,较去年同期显著增长。报告期内,抖音平台 第三方产 ...
俞敏洪:东方甄选计划于今年成立电商培训学校
Bei Jing Shang Bao· 2026-02-10 11:20
北京商报讯(记者 何倩)2月10日,北京商报记者获悉,近日新东方创始人、东方甄选CEO俞敏洪在直 播间宣布,东方甄选计划于今年正式成立电商培训学校。在直播中,俞敏洪称,布局电商培训的原因是 许多各地相关部门对电商非常重视,希望派人来培训。 "所以我们干脆在北京准备成立一个电商学校,让各个地方派这些电商的运营人才、主播等,到北京去 培训。"俞敏洪说道。 据了解,早在2022年6月,俞敏洪曾透露新东方未来可能会开设电商学院。 ...
俞敏洪要开电商培训学校!东方甄选股价跌超9%
Sou Hu Cai Jing· 2026-02-10 10:00
Group 1 - The core idea of the news is that Oriental Selection plans to establish an e-commerce training school in Beijing to enhance the skills of e-commerce operators and live streamers, as announced by its founder, Yu Minhong [1][3]. - The initiative is driven by the increasing emphasis from local authorities on e-commerce training, with Yu Minhong expressing the belief that collaborative exploration is more effective than solitary efforts [1][3]. - Yu Minhong previously mentioned the need for cultural training for e-commerce live streamers to elevate the overall quality of Chinese hosts, indicating his personal involvement in the training process [3]. Group 2 - For the fiscal year 2026, Oriental Selection reported a total revenue of 2.312 billion yuan, a year-on-year increase of 5.7%, with an actual growth rate of 17% when excluding the impact of the previous year's revenue [3]. - The company achieved a net profit of 239 million yuan, marking a significant turnaround from a net loss of 96.79 million yuan in the same period last year, representing a growth of 347.7% [3]. - The total GMV for self-operated products and live e-commerce business reached 4.1 billion yuan, reflecting a 16.4% increase compared to the 3.6 billion yuan in the first half of the fiscal year 2025 [3]. Group 3 - The channel structure continues to optimize, with Douyin remaining the core source of traffic, while the contribution of GMV from the Oriental Selection app increased to 18.5%, a significant rise from the previous year [3]. - The total number of paid orders for third-party and self-operated products on Douyin reached approximately 42.1 million, indicating sustained high consumer engagement [3]. - Despite a 9.49% drop in stock price to 29.2 HKD, the market capitalization stands at 30.775 billion HKD, with a notable 30% increase in stock price following the earnings announcement [4].
俞敏洪:东方甄选2026年要开电商培训学校
Xin Lang Ke Ji· 2026-02-10 08:38
Group 1 - The core idea of the news is that New Oriental, led by founder Yu Minhong, plans to establish an e-commerce training school this year to enhance the skills of e-commerce operators and live streamers in China [2][3] - The initiative is driven by the increasing emphasis from local authorities on e-commerce training, with a focus on collaborative learning rather than isolated efforts [2] - The training school will be located in Beijing, a hub for talent, allowing for the recruitment of experienced instructors to provide quality education [2] Group 2 - Yu Minhong had previously expressed the idea of creating an e-commerce academy during a live stream last year, highlighting the need for cultural training for e-commerce live streamers [3] - The goal of the training is not solely for profit but to elevate the overall quality of Chinese live streamers [3] - Yu Minhong intends to personally teach at the academy and will also invite renowned streamers to participate in the training [3]
港股收盘,恒指收涨0.58%,科指收涨0.62%;乐欣户外(02720.HK)首日上市收涨超100%,石药集团(01093.HK)涨超5.5%,信达生物...




Jin Rong Jie· 2026-02-10 08:28
Group 1 - The Hong Kong stock market closed with the Hang Seng Index rising by 0.58% and the Tech Index increasing by 0.62% [1] - Le Xin Outdoor (02720.HK) saw a first-day listing surge of over 100% [1] - CSPC Pharmaceutical Group (01093.HK) experienced a rise of over 5.5% [1] - Innovent Biologics (01801.HK) and Pop Mart (09992.HK) both increased by nearly 5% [1] - Oriental Selection (01797.HK) faced a decline of nearly 10% [1]
港股午评:恒生指数涨0.54%,恒生科技指数涨0.84%




Xin Lang Cai Jing· 2026-02-10 04:08
港股午间收盘,恒生指数涨0.54%,恒生科技指数涨0.84%。板块方面,酒店和度假村REIT、生物科技 板块涨幅靠前;客运航空公司、保险板块跌幅靠前。个股方面,智谱涨21.03%,阅文集团涨15.57%, 阜博集团涨13.35%,宝济药业-B涨10.34%,联合集团涨9.43%;招金矿业跌5.95%,东方甄选跌5.83%, 五一视界跌5.48%,轻松健康跌5.4%,瑞丰动力跌4.94%。 来源:滚动播报 ...
——海外消费周报(20260130-20260205):港股医药 2025 年报业绩前瞻:商业化销售放量叠加授权收入,部分公司有望迎来盈利拐点-20260208
Shenwan Hongyuan Securities· 2026-02-08 13:37
Investment Rating - The report indicates a positive outlook for the pharmaceutical sector, particularly for innovative drugs and companies expected to reach profitability in 2025 [1][9][15]. Core Insights - The innovative drug sector is anticipated to see significant growth due to the commercialization of core products and contributions from business development (BD) revenues, with companies like BeiGene, Innovent Biologics, and others expected to achieve profitability [1][9]. - The Pharma sub-sector is projected to experience a revenue growth rate of 15-20% in 2025, with notable companies such as Hansoh Pharmaceutical and China Biologic Products leading this growth [2][10]. - The CXO sector is also expected to report strong performance, with companies like WuXi AppTec forecasting substantial revenue and profit increases [3][11]. - The medical services sector is currently valued at historical lows, with a projected revenue growth of 13% for Genscript Biotech, highlighting the importance of monitoring industry changes [4][12]. Summary by Sections Innovative Drugs - Companies expected to achieve profitability in 2025 include BeiGene, Innovent Biologics, and others, driven by increased commercialization and BD revenues [1][9]. Pharma - Revenue growth of 15-20% is expected for leading companies such as Hansoh Pharmaceutical and China Biologic Products, with a significant boost anticipated for 3SBio due to a major BD deal with Pfizer [2][10]. CXO - WuXi AppTec is projected to achieve approximately 454.56 billion RMB in revenue, reflecting a year-on-year growth of about 15.84%, with adjusted net profits expected to rise significantly [3][11]. Medical Services - Genscript Biotech is expected to see a revenue increase of 13% in 2025, emphasizing the need to focus on overseas business expansion and AI integration in traditional medicine [4][12].